QuidelOrtho Acquires LEX Diagnostics to Expand Ultra-Fast Point-of-Care PCR

Leinco Technologies Acquires QED Biosciences from Genovis

September 3, 2024

Biotechnology

Leinco Technologies, a portfolio company backed by Ampersand Capital Partners, has acquired Genovis-owned QED Biosciences to expand its catalog of antibodies, recombinant proteins and IVD raw materials. The deal transfers Genovis' antibody business to Leinco and strengthens Leinco's antibody development and IVD support capabilities for research and diagnostics customers worldwide.

Roche to Acquire LumiraDx Point-of-Care Technology Platform for $295 Million

January 2, 2024

Healthcare Services

LumiraDx has entered into a definitive agreement for Roche to acquire certain companies and related assets within LumiraDx’s point-of-care diagnostics platform business. Roche will pay $295 million at closing, with an additional payment of up to $55 million for reimbursement to fund the platform business until closing.

Leica Biosystems Acquires Cell IDx

November 8, 2022

Biotechnology

Leica Biosystems has acquired Cell IDx, a San Diego-based leader in multiplexed tissue profiling, integrating Cell IDx's UltraPlex multiplex IHC technology with Leica's BOND RX automation to expand translational research and multiplexing capabilities. The deal advances Leica's research-focused staining and imaging portfolio and brings scale-up and medical/scientific affairs support for Cell IDx customers.

Quidel Acquires Ortho Clinical Diagnostics to Form QuidelOrtho

May 27, 2022

Healthcare Services

Quidel agreed to acquire Ortho Clinical Diagnostics in a cash-and-stock deal valued at approximately $6.0 billion, combining complementary in vitro diagnostics portfolios. The transaction was later completed, creating QuidelOrtho, headquartered in San Diego, and bringing together roughly 6,000 employees and more than $3.5 billion in combined 2021 revenue.

EKF Diagnostics Acquires ADL Health (Advanced Diagnostic Laboratory LLC)

November 11, 2021

Healthcare Services

EKF Diagnostics has acquired Advanced Diagnostic Laboratory LLC (ADL Health), a Texas-based CLIA-certified molecular diagnostics laboratory focused on PCR and high-throughput COVID-19 testing. The acquisition expands EKF's diagnostics capability by adding clinical laboratory testing services and ISO 15189-accredited operations to support a broader ‘sample-to-result’ offering and anticipated investment in equipment and personnel.

Prenetics / DNAFit Acquire Oxsed (Oxford University Spin-out)

October 28, 2020

Medical Devices

Hong Kong-based Prenetics, via its UK entity DNAFit Life Sciences Limited, has acquired Oxsed, an Oxford University spin-out that developed a rapid RT-LAMP COVID-19 testing platform. The acquisition gives DNAFit/Prenetics exclusive global rights to the Oxsed technology to accelerate R&D, scale manufacturing and deploy rapid point-of-care testing (including airport trials) worldwide.